KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Asset Writedowns and Impairment: 2009-2024

Historic Asset Writedowns and Impairment for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $250,000.

  • Idexx Laboratories' Asset Writedowns and Impairment was N/A to $250,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $3.6 million, marking a year-over-year change of. This contributed to the annual value of $250,000 for FY2024, which is 83.15% down from last year.
  • Per Idexx Laboratories' latest filing, its Asset Writedowns and Impairment stood at $250,000 for FY2024, which was down 83.15% from $1.5 million recorded in FY2023.
  • Idexx Laboratories' Asset Writedowns and Impairment's 5-year high stood at $5.1 million during FY2021, with a 5-year trough of $250,000 in FY2024.
  • Its 3-year average for Asset Writedowns and Impairment is $1.4 million, with a median of $1.5 million in 2023.
  • As far as peak fluctuations go, Idexx Laboratories' Asset Writedowns and Impairment skyrocketed by 158.37% in 2020, and later tumbled by 83.15% in 2024.
  • Yearly analysis of 5 years shows Idexx Laboratories' Asset Writedowns and Impairment stood at $2.5 million in 2020, then skyrocketed by 105.84% to $5.1 million in 2021, then plummeted by 54.43% to $2.3 million in 2022, then tumbled by 36.74% to $1.5 million in 2023, then crashed by 83.15% to $250,000 in 2024.